Prescribing of two potentially interacting cardiovascular medications in atrial fibrillation patients on direct oral anticoagulants

BACKGROUND: Amiodarone and diltiazem are commonly recommended cardiovascular medications for use in atrial fibrillation (AF) patients. They are known to have drug-drug interactions (DDIs) with direct oral anticoagulants (DOACs). We aimed to evaluate frequency of use of amiodarone or diltiazem among...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Cardiol Heart Vasc
Hlavní autoři: Shurrab, Mohammed, Koh, Maria, Jackevicius, Cynthia A., Qiu, Feng, Conlon, Michael, Caswell, Joseph, Tu, Karen, Austin, Peter C., Ko, Dennis T.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Original Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105295/
https://ncbi.nlm.nih.gov/pubmed/33997261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2021.100788
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky